NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球體外受精市場(2020-2030年):市場預測(按產品/類型/治療類別/最終用戶)/國家/地區數據(16個國家/地區)/競爭分析

Global In-Vitro Fertilization Market: Focus on Products, Types, Procedures, and End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030

出版商 BIS Research Inc. 商品編碼 1001386
出版日期 內容資訊 英文 301 Pages
商品交期: 最快1-2個工作天內
價格
全球體外受精市場(2020-2030年):市場預測(按產品/類型/治療類別/最終用戶)/國家/地區數據(16個國家/地區)/競爭分析 Global In-Vitro Fertilization Market: Focus on Products, Types, Procedures, and End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030
出版日期: 2021年04月12日內容資訊: 英文 301 Pages
簡介

在預測期內,全球體外受精市場將保持9.37%的複合年增長率,預計到2030年將增長至515.1億美元。

由於生活方式的改變(例如初生中位數年齡的增加)而導致的不孕症的增加,正在推動市場的增長。

該報告調查了全球體外受精市場,定義和概述了市場,分析了新的冠狀病毒感染(COVID-19)和其他市場影響因素,監管和報銷環境以及專利趨勢。 ,產品/類型/處理類別/最終用戶/地區/主要國家等,按各種類別細分,競爭環境,主要公司的概況等。

執行摘要

第1章市場定義

第2章調查範圍

第3章調查方法

第4章全球體外受精市場:概述

  • 市場定義
  • 市場規模/增長潛力
  • 未來潛力
  • COVID-19的影響

第5章工業分析

  • 政策/法規框架
  • 贖回分析
  • 專利分析
  • 成本/價格趨勢

第6章市場動態

  • 概述
  • 增長動力
  • 市場問題
  • 市場機會

第7章競爭考慮

  • 主要戰略/發展(供應商)
  • 市場份額分析
  • 增長份額分析

第8章市場分析/預測:按產品分類

  • 概述
  • 系統
    • 配子收集/分類系統
    • 樣品處理系統
    • 儲存/維護系統
    • 其他
  • 介質/試劑
    • 胚胎培養基/試劑
    • 冷凍保存介質/試劑
    • 配子處理介質/試劑
    • 其他
    • 配件/耗材

第9章市場分析/預測:按類型

  • 概述
  • 常規試管嬰兒
  • 胞漿內精子注射(ICSI)

第10章市場分析/預測:按治療類別

  • 概述
  • 新鮮的捐助者
  • 新鮮的非捐助者
  • 冷凍捐助者
  • 凍結的非捐贈者

第11章市場分析/預測:按最終用戶分類

  • 概述
  • 商業實驗室
  • 不孕症診所
  • 醫院系統
  • 其他

第12章市場分析/預測:按地區/主要國家/地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 其他地區

第13章公司簡介

  • The Suppliers
  • The Cooper Companies Inc.
  • Vitrolife AB
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Cook Medical
  • FUJIFILM Irvine Scientific
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Esco Group of Companies
  • IVFtech ApS
  • Kitazato Corporation
  • Service Providers
  • Care Fertility
  • Laboratory Corporation of America Holdings (Labcorp)
  • Genea Limited
  • Natera, Inc.
  • Invitae Corporation
  • Progyny, Inc.
  • Kaiser Permanente
  • Boston IVF
  • Monash IVF Group
目錄
Product Code: BHL0403SB

“Global In-Vitro Fertilization Market to Reach $51.51 Billion by 2030.”

Market Report Coverage - In-Vitro Fertilization

Market Segmentation

  • Product - Systems, Media and Reagents, Accessories and Consumables
  • Type - Conventional IVF, IVF with Intracytoplasmic Sperm Injection (ICSI)
  • Procedure - Fresh Donor, Fresh Non-donor, Frozen Donor, Frozen Non-donor
  • End User - Commercial Labs, Fertility Clinics, Hospital Systems, Other End Users

Regional Segmentation

  • North America - U.S., Canada
  • Europe - Germany, France, Italy, U.K., Spain, Russia, Netherlands, Rest-of-Europe
  • Asia-Pacific - Japan, China, India, South Korea, Australia, Singapore, Rest-of-APAC
  • Latin America - Brazil, Mexico
  • Rest-of-the-World

Growth Drivers

  • Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
  • High Success Rate of IVF Treatment
  • Increasing Demand for Infertility Treatment to Support Aging Population
  • Impact of Fertility Tourism

Market Challenges

  • Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries
  • Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations
  • Ethical Issues and Social Justice

Market Opportunities

  • Technological Advancements of Time-Lapse Technology
  • Advances in Embryo Biopsy and Genetic Screening

Key In-Vitro Fertilization Companies Profiled:

  • Suppliers - Cooper Companies Inc., Vitrolife AB, Illumina, Inc., Agilent Technologies, Inc., Cook Medical Inc., Fujifilm Irvine Scientific Inc., F. Hoffmann-La Roche Ltd., GE Healthcare, Abbott Laboratories, Thermo Fisher Scientific Inc., Merck KGaA, Esco Micro Pte. Ltd., IVFtech APS, and Kitazato Corporation.
  • Service Providers - CARE Fertility, Laboratory Corporation of America Holdings, Genea Limited, Natera, Inc., Invitae Corporation, Kaiser Permanente, Progyny, Inc., Boston IVF, and Monash IVF Group

Key Questions Answered in this Report:

  • What is in-vitro fertilization?
  • What are different types of systems, media, and reagents available in the market, and what are they used for? What are the key companies offering these devices and reagents? What would be the global market value for each of these systems, media, and reagents for the time between 2020 and 2030?
  • Based on systems, which IVF system type is anticipated to witness a massive rise in the demand in the forecast period? Based on reagents, which reagent type is anticipated to witness a massive rise in the demand in the forecast period?
  • What are the different testing services involved in IVF procedures, and what are the key companies offering them? What would be the global market value for services for the period 2019-2030?
  • What are the major drivers, challenges, and opportunities of the global IVF market?
  • What are the key developmental strategies implemented by the key players to stand out in this market?
  • What are the leading companies dominating the global IVF market? What is the share of these companies in the global IVF market?
  • What are the regulations pertaining to the global IVF market? What initiatives are implemented by different government bodies regulating the development and commercialization of IVF devices?
  • By end-user type, what would the market value of the leading segments of the global IVF market be? By procedure type, what would the market value of the leading segments of the global IVF market be?
  • How will each segment of the global IVF market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2030?
  • How will the industry evolve during the forecast period 2020-2030?
  • What is the market scenario for the IVF services market in different regions?
  • What are the key trends of different regions in the IVF market? Which country would contribute to the highest sales of the IVF market during the forecast period 2020-2030?

Market Overview

Infertility is a serious health issue worldwide, affecting approximately 8%-10% of couples worldwide. According to CDC, 2013 and Office on Women's Health, 2019 reports, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the U.S., and according to the Reproductive Biological Endocrinology, 2015 report, around 48.5 million couples experience infertility, globally. In response to these issues, countries across the globe are striving hard to increase their fertility rates, thereby promoting high adoption of assisted reproductive technologies (ART). ART are cutting-edge technologies that help to treat infertility by manipulating sperm and/or eggs outside the human body.

The global in-vitro fertilization market consists of systems, media, and reagents, and pharmaceuticals used to carry out the entire procedure, from monitoring and stimulating a woman's ovulatory process to the final implantation of the embryo into the concerned woman's fallopian tube to bringing out a successful pregnancy. The increasing incidence of infertility owing to lifestyle changes, such as an increase in the median age of first-time motherhood, is a major factor contributing to the growth of the global in-vitro fertilization market.

Our healthcare experts have found in-vitro fertilization to be one of the most rapidly evolving techniques, and the global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030. An increase in the trend of delayed pregnancies, changing lifestyles in urban areas, and increased age of parenthood bolster the growth of the global IVF market. The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global IVF market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of products and services available in the market and their impact on the healthcare sector by providing critical insights into the direction of its future expansion.

The global IVF market is largely dominated by companies such as The Cooper Companies Inc., Vitrolife AB, Cook Medical, Merck KGaA, Fujifilm Holdings Corporation, and other enterprises. Declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.

Based on region, Europe is the dominating region for the global in-vitro fertilization market in the year 2019. Low fertility rates and flexible government regulations are the two most prominent factors contributing to the growth of the IVF market in Europe. In the Asia-Pacific region, China, Japan, India, Australia, and New Zealand are among the top five countries generating the highest revenues compared to other countries of the region.

Within the research report, the market is segmented based on product, services, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

Competitive Landscape

The global IVF market is distributed among suppliers and service providers. Cooper Surgical, Vitrolife AB, Merck KGaA, and Cook Medical are some of the key suppliers to this market. Among the service providers, companies like Progyny, Natera, and Invitae Corp. are the major service providers offering IVF diagnostic and testing services.

The global in-vitro fertilization market is currently dominated by Cooper Companies, Inc., followed by Vitrolife AB. The market dominance of Cooper Companies, Inc. can be attributed to a large product offering in media, reagents, and consumables segments. Merck KGaA holds the third largest share, owing to its diverse range of product offerings in consumables (including media, kits, and accessories) and systems.

Table of Contents

Executive Summary

1 Market Definition

  • 1.1 Inclusions and Exclusions
    • 1.1.1 Inclusions
    • 1.1.2 Exclusions

2 Research Scope

  • 2.1 Key Questions Answered in the Report

3 Research Methodology

  • 3.1 In-Vitro Fertilization: Research Methodology
  • 3.2 Primary Data Sources
  • 3.3 Secondary Data Sources
  • 3.4 Market Estimation Model
  • 3.5 Criteria for Company Profiling

4 Global In-Vitro Fertilization Market: Overview

  • 4.1 Market Definition
    • 4.1.1 Steps Involved in IVF
    • 4.1.2 Additional IVF Procedures
  • 4.2 Market Size and Growth Potential, $Million, 2019-2030
  • 4.3 Global IVF Market: Future Potential
  • 4.4 Impact of COVID-19 on In-Vitro Fertilization Market

5 Global In-Vitro Fertilization Market: Industry Analysis

  • 5.1 Policies and Regulatory Framework
    • 5.1.1 Overview
    • 5.1.2 International Federation of Gynecology and Obstetrics (FIGO)
    • 5.1.3 Regulatory Framework in the U.S.
    • 5.1.4 International Federation of Fertility Societies (IFFS)
    • 5.1.5 Regulatory Framework in EU4 and U.K.
    • 5.1.6 Regulatory Framework in Asia-Pacific
    • 5.1.7 Asia-Pacific Initiative on Reproduction (ASPIRE)
  • 5.2 Reimbursement Analysis
    • 5.2.1 U.S.
    • 5.2.2 EU4 and U.K.
    • 5.2.3 Asia-Pacific
  • 5.3 Patent Analysis
    • 5.3.1 By Country
    • 5.3.2 By Year
  • 5.4 Cost and Pricing Trends

6 Market Dynamics

  • 6.1 Overview
  • 6.2 Market Drivers
    • 6.2.1 Growth in Median Age of First-Time Motherhood and Declining Fertility Rates
    • 6.2.2 High Success Rate of IVF Treatment
    • 6.2.3 Increasing Demand for Infertility Treatment to Support Aging Population
    • 6.2.4 Impact of Fertility Tourism
  • 6.3 Market Challenges
    • 6.3.1 Unaffordable Cost of Assisted Reproductive Techniques (ART) and Genetic Testing in Low- and Middle- Income Countries
    • 6.3.2 Lack of Guidelines and Regulations, and Low Awareness of IVF Treatment in Some Under-Developed and Developing Nations
    • 6.3.3 Ethical Issues and Social Justice
  • 6.4 Market Opportunities
    • 6.4.1 Technological Advancements of Time-Lapse Technology
    • 6.4.2 Advances in Embryo Biopsy and Genetic Screening

7 Global In-Vitro Fertilization Market: Competitive Insights

  • 7.1 Overview
  • 7.2 Key Strategies and Development (Suppliers)
    • 7.2.1 Synergistic Activities
    • 7.2.2 Regulatory Accreditations, Recognitions, Investments, and Expansions
    • 7.2.3 Product and Service Launches
    • 7.2.4 Mergers and Acquisitions, Partnership, and Collaborations
    • 7.2.5 Approvals
  • 7.3 Market Share Analysis
  • 7.4 Growth-Share Analysis

8 Global IVF Market (by Product), $Million, 2019-2030

  • 8.1 Overview
  • 8.2 Systems
    • 8.2.1 Gamete Collection and Sorting Systems
    • 8.2.2 Sample Handling Systems
    • 8.2.3 Storage and Maintenance Systems
    • 8.2.4 Other IVF Systems
  • 8.3 Media and Reagents
    • 8.3.1 Embryo Culture Media and Reagents
    • 8.3.2 Cryopreservation Media and Reagents
    • 8.3.3 Gamete Processing Media and Reagents
    • 8.3.4 Other Media and Reagents
    • 8.3.5 Accessories and Consumables

9 Global IVF Market (by Type), $Million, 2019-2030

  • 9.1 Overview
  • 9.2 Conventional IVF
  • 9.3 IVF with Intracytoplasmic Sperm Injection (ICSI)

10 Global IVF Market (by Procedure), $Million, 2019-2030

  • 10.1 Overview
  • 10.2 Fresh Donor
  • 10.3 Fresh Non-donor
  • 10.4 Frozen Donor
  • 10.5 Frozen Non-donor

11 Global IVF Market (by End User), $Million, 2019-2030

  • 11.1 Overview
  • 11.2 Commercial Labs
  • 11.3 Fertility Clinics
  • 11.4 Hospital Systems
  • 11.5 Other End Users

12 Global In-Vitro Fertilization Market, (by Region), Value & Volume, 2019-2030

  • 12.1 Overview
    • 12.1.1 Global In-Vitro Fertilization Market (by Region), 2019-2030
  • 12.2 Growth Potential Analysis (by Country)
  • 12.3 North America
    • 12.3.1 Key Dynamics
    • 12.3.2 U.S.
      • 12.3.2.1 U.S. In-Vitro Fertilization Market
      • 12.3.2.2 IVF Test Volume (Units), 2019-2030
      • 12.3.2.3 Number of Operating IVF Labs
    • 12.3.3 Canada
      • 12.3.3.1 Canada In-Vitro Fertilization Market
      • 12.3.3.2 IVF Test Volume (Units), 2019-2030
      • 12.3.3.3 Number of Operating IVF Labs
    • 12.3.4 North America In-Vitro Fertilization Market (by Procedure)
    • 12.3.5 North America In-Vitro Fertilization Market (by End User)
  • 12.4 Europe
    • 12.4.1 Key Dynamics
    • 12.4.2 Germany
      • 12.4.2.1 IVF Test Volume (Units), 2019-2030
      • 12.4.2.2 Number of Operating IVF Labs
    • 12.4.3 France
      • 12.4.3.1 IVF Test Volume (Units), 2019-2030
      • 12.4.3.2 Number of Operating IVF Labs
    • 12.4.4 U.K.
      • 12.4.4.1 IVF Test Volume (Units), 2019-2030
      • 12.4.4.2 Number of Operating IVF Labs
    • 12.4.5 Italy
      • 12.4.5.1 IVF Test Volume (Units), 2019-2030
      • 12.4.5.2 Number of Operating IVF Labs
    • 12.4.6 Spain
      • 12.4.6.1 IVF Test Volume (Units), 2019-2030
      • 12.4.6.2 Number of Operating IVF Labs
    • 12.4.7 Netherlands
      • 12.4.7.1 IVF Test Volume (Units), 2019-2030
      • 12.4.7.2 Number of Operating IVF Labs (2019)
    • 12.4.8 Russia
      • 12.4.8.1 IVF Test Volume (Units), 2019-2030
      • 12.4.8.2 Number of Operating IVF Labs
    • 12.4.9 Rest-of-Europe
    • 12.4.10 Europe In-Vitro Fertilization Market (by Procedure)
    • 12.4.11 Europe In-Vitro Fertilization Market (by End User)
  • 12.5 Asia-Pacific
    • 12.5.1 Key Dynamics
    • 12.5.2 Japan
      • 12.5.2.1 IVF Test Volume (Units), 2019-2030
      • 12.5.2.2 Number of Operating IVF Labs
    • 12.5.3 China
      • 12.5.3.1 IVF Test Volume (Units), 2019-2030
      • 12.5.3.2 Number of Operating IVF Labs
    • 12.5.4 Australia
      • 12.5.4.1 IVF Test Volume (Units), 2019-2030
      • 12.5.4.2 Number of Operating IVF Labs
    • 12.5.5 India
      • 12.5.5.1 IVF Test Volume (Units), 2019-2030
      • 12.5.5.2 Number of Operating IVF Labs
    • 12.5.6 South Korea
      • 12.5.6.1 IVF Test Volume (Units), 2019-2030
      • 12.5.6.2 Number of Operating IVF Labs
    • 12.5.7 Singapore
      • 12.5.7.1 IVF Test Volume (Units), 2019-2030
      • 12.5.7.2 Number of Operating IVF Labs
    • 12.5.8 Rest-of-APAC
      • 12.5.8.1 IVF Test Volume (Units), 2019-2030
    • 12.5.9 APAC In-Vitro Fertilization Market (by Procedure)
    • 12.5.10 APAC In-Vitro Fertilization Market (by End User)
  • 12.6 Latin America
    • 12.6.1 Key Dynamics
    • 12.6.2 Brazil
      • 12.6.2.1 IVF Test Volume (Units), 2019-2030
      • 12.6.2.2 Number of Operating IVF Labs
    • 12.6.3 Mexico
      • 12.6.3.1 IVF Test Volume (Units), 2019-2030
      • 12.6.3.2 Number of Operating IVF Labs
    • 12.6.4 Rest-of-Latin America
    • 12.6.5 Latin America In-Vitro Fertilization Market (by Procedure)
    • 12.6.6 Latin America In-Vitro Fertilization Market (by End User)
  • 12.7 Rest-of-the-World
    • 12.7.1 Rest-of-the-World In-Vitro Fertilization Market (by Procedure)
    • 12.7.2 Rest-of-the-World In-Vitro Fertilization Market (by End User)

13 Company Profiles

  • 13.1 Overview
  • 13.2 The Suppliers
  • 13.3 The Cooper Companies Inc.
    • 13.3.1 Company Overview
    • 13.3.2 Role of the Cooper Companies Inc. in the Global IVF Market
    • 13.3.3 Financials
      • 13.3.3.1 Key Insights About Financial Health of the Company
    • 13.3.4 SWOT Analysis
  • 13.4 Vitrolife AB
    • 13.4.1 Company Overview
    • 13.4.2 Role of Vitrolife AB in the Global IVF market
    • 13.4.3 Financials
      • 13.4.3.1 Key Insights About Financial Health of the Company
    • 13.4.4 SWOT Analysis
  • 13.5 Illumina, Inc.
    • 13.5.1 Company Overview
    • 13.5.2 Role of Illumina, Inc. in the Global In-Vitro Fertilization Market
    • 13.5.3 Financials
    • 13.5.4 Key Insights About Financial Health of the Company
    • 13.5.5 SWOT Analysis
  • 13.6 Agilent Technologies, Inc.
    • 13.6.1 Company Overview
    • 13.6.2 Role of Agilent Technologies, Inc. in the Global In-Vitro Fertilization Market
    • 13.6.3 Financials
    • 13.6.4 Key Insights About Financial Health of the Company
    • 13.6.5 SWOT Analysis
  • 13.7 Cook Medical
    • 13.7.1 Company Overview
    • 13.7.2 Role of Cook Medical in the Global IVF market
    • 13.7.3 SWOT Analysis
  • 13.8 FUJIFILM Irvine Scientific
    • 13.8.1 Company Overview
    • 13.8.2 Role of FUJIFILM Irvine Scientific in the Global IVF market
    • 13.8.3 SWOT Analysis
  • 13.9 F. Hoffmann-La Roche Ltd
    • 13.9.1 Company Overview
    • 13.9.2 Role of F. Hoffmann-La Roche Ltd. in the Global In-Vitro Fertilization Market
    • 13.9.3 Financials
    • 13.9.4 Key Insights About Financial Health of the Company
    • 13.9.5 SWOT Analysis
  • 13.1 GE Healthcare
    • 13.10.1 Company Overview
    • 13.10.2 Role of GE Healthcare in the Global In-Vitro Fertilization Market
    • 13.10.3 Financials
    • 13.10.4 SWOT Analysis
  • 13.11 Abbott Laboratories
    • 13.11.1 Company Overview
    • 13.11.2 Role of Abbott Laboratories plc in the Global In-Vitro Fertilization Market
    • 13.11.3 Financials
    • 13.11.4 Key Insights About Financial Health of the Company
    • 13.11.5 SWOT Analysis
  • 13.12 Thermo Fisher Scientific, Inc.
    • 13.12.1 Company Overview
    • 13.12.2 Role of Thermo Fisher Scientific, Inc. in the Global In-Vitro Fertilization Market
    • 13.12.3 Financials
    • 13.12.4 R&D Expenditure, 2018-2020
    • 13.12.5 SWOT Analysis
  • 13.13 Merck KGaA
    • 13.13.1 Company Overview
    • 13.13.2 Role of Merck KGaA in the Global In-Vitro Fertilization Market
    • 13.13.3 Financials
    • 13.13.4 SWOT Analysis
  • 13.14 Esco Group of Companies
    • 13.14.1 Company Overview
    • 13.14.2 Role of Esco Group of Companies in the Global IVF Market
    • 13.14.3 SWOT Analysis
  • 13.15 IVFtech ApS
    • 13.15.1 Company Overview
    • 13.15.2 Role of IVFtech ApS in the Global IVF Market
    • 13.15.3 SWOT Analysis
  • 13.16 Kitazato Corporation
    • 13.16.1 Company Overview
    • 13.16.2 Role of Kitazato Corporation in the Global In-Vitro Fertilization Market
    • 13.16.3 SWOT Analysis
  • 13.17 Service Providers
  • 13.18 Care Fertility
    • 13.18.1 Company Overview
    • 13.18.2 Role of Care Fertility in the Global In-Vitro Fertilization Market
    • 13.18.3 SWOT Analysis
  • 13.19 Laboratory Corporation of America Holdings (Labcorp)
    • 13.19.1 Company Overview
    • 13.19.2 Role of Labcorp in the Global In-Vitro Fertilization Market
    • 13.19.3 Financials
    • 13.19.4 SWOT Analysis
  • 13.2 Genea Limited
    • 13.20.1 Company Overview
    • 13.20.2 Role of Genea Limited in the Global In-Vitro Fertilization Market
    • 13.20.3 SWOT Analysis
  • 13.21 Natera, Inc.
    • 13.21.1 Company Overview
    • 13.21.2 Role of Natera Inc. in the Global In-Vitro Fertilization Market
    • 13.21.3 Financials
    • 13.21.4 SWOT Analysis
  • 13.22 Invitae Corporation
    • 13.22.1 Company Overview
    • 13.22.2 Role of Invitae Corporation in the Global In-Vitro Fertilization Market
    • 13.22.3 Financials
    • 13.22.4 SWOT Analysis
  • 13.23 Progyny, Inc.
    • 13.23.1 Company Overview
    • 13.23.2 Role of Progyny, Inc. in the Global In-Vitro Fertilization Market
    • 13.23.3 Financials
    • 13.23.4 SWOT Analysis
  • 13.24 Kaiser Permanente
    • 13.24.1 Company Overview
    • 13.24.2 Role of Kaiser Permanente in the Global In-Vitro Fertilization Market
    • 13.24.3 SWOT Analysis
  • 13.25 Boston IVF
    • 13.25.1 Company Overview
    • 13.25.2 Role of Boston IVF in the Global In-Vitro Fertilization Market
    • 13.25.3 SWOT Analysis
  • 13.26 Monash IVF Group
    • 13.26.1 Company Overview
    • 13.26.2 Role of Monash IVF in the Global In-Vitro Fertilization Market
    • 13.26.3 Financials
    • 13.26.4 SWOT Analysis

List of Tables

  • Table 5.1: Cost of Different Types of IVF Procedures
  • Table 5.2: Cost of Genetic Testing for IVF
  • Table 8.1: Examples of Systems Offered by Key Companies
  • Table 8.2: Examples of Ovum Aspiration Pump Products Developed by Key Companies
  • Table 8.3: Examples of Imaging System Products Developed by Key Companies
  • Table 8.4: Examples of Micromanipulator Products Developed by Key Companies
  • Table 8.5: Examples of Laser System Products Developed by Key Companies
  • Table 8.6: Examples of Workstation and Cabinet Products Developed by Key Companies
  • Table 8.7: Examples of Incubator Products Developed by Key Companies
  • Table 8.8: Examples of Cryosystem Products Developed by Key Companies
  • Table 8.9: Examples of Analyzer and Regulator Products Developed by Key Companies
  • Table 8.10: Examples of Table Products Developed by Key Companies
  • Table 8.11: Examples of Witness System Products Developed by Key Companies
  • Table 8.12: Examples of Devices (under Others Category) Developed by Key Companies
  • Table 8.13: Examples of Reagent Types Offered by Key Companies
  • Table 8.14: Examples of Embryo Culture Media and Reagents Products Developed by Key Companies
  • Table 8.15: Examples of Cryopreservation Media and Reagents Developed by Key Companies
  • Table 8.16: Examples of Gamete Processing Media and Reagents Developed by Key Companies
  • Table 8.17: Examples of Media and Reagents (Others) Developed by Key Companies
  • Table 8.18: Examples of Accessories and Consumables Developed by Key Companies

List of Figures

  • Figure 1: Global In-Vitro Fertilization Market, $Million, 2020-2030
  • Figure 2: Global In-Vitro Fertilization: Impact Analysis
  • Figure 3: Global In-Vitro Fertilization Market (by Component), $Million, 2019, 2025, and 2030
  • Figure 4: Global In-Vitro Fertilization Market (by Product Type), $Million, 2019, 2025, and 2030
  • Figure 5: Global In-Vitro Fertilization Market (by Procedure), $Million, 2020 and 2030
  • Figure 6: Global IVF Market Share (by End User Type), 2020 and 2030
  • Figure 7: Global IVF Market (by Region), 2020 and 2030
  • Figure 2.1: Global In-Vitro Fertilization Market (by Segment)
  • Figure 3.1: Global In-Vitro Fertilization Market Methodology
  • Figure 3.2: Primary Research Methodology
  • Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
  • Figure 4.1: Process of IVF
  • Figure 4.2: Global In-Vitro Fertilization (IVF) Market, 2019-2030
  • Figure 4.3: Impact of COVID-19 on the Global In-Vitro Fertilization Market
  • Figure 5.1: Patent Analysis, by Country (2018-2021)
  • Figure 5.2: Patent Analysis, by Year (2018-2021)
  • Figure 7.1: Synergistic Activities (by Suppliers), July 2016-December 2020
  • Figure 7.2: Company Share (by Synergistic Activity), January 2016-December 2020
  • Figure 7.3: Regulatory Accreditations, Recognitions, Investments, and Expansions Share (by Company), January 2016-December 2020
  • Figure 7.4: Product and Service Launch Share by Company, January 2016-January 2020
  • Figure 7.5: M&A, Partnerships and Collaborations Share, January 2016-December 2020
  • Figure 7.6: Approvals (by Company), January 2016-January 2020
  • Figure 7.7: Market Share Analysis (by Suppliers), 2019
  • Figure 7.8: Growth-Share Matrix for Global In-Vitro Fertilization Market (by Company), 2019
  • Figure 7.9: Growth-Share Matrix for Global In-Vitro Fertilization Market (by Procedure), 2019
  • Figure 7.10: Growth Share Matrix for Global In-Vitro Fertilization Market (by Region), 2019
  • Figure 8.1: Global IVF Market (by Product), 2020 and 2030
  • Figure 8.2: Global IVF Systems Market, 2020-2030
  • Figure 8.3: Global IVF Devices Market (by Systems), 2020 and 2030
  • Figure 8.4: Global Gamete Collection and Sorting Systems Market, 2019-2030
  • Figure 8.5: Global IVF Sample Handling Systems Market, 2019-2030
  • Figure 8.6: Global IVF Storage and Maintenance Systems Market, 2019-2030
  • Figure 8.7: Global Other IVF Systems Market, 2019-2030
  • Figure 8.8: Global IVF Media and Reagents Market, 2019-2030
  • Figure 8.9: Global IVF Market (by Media and Reagents), 2020 and 2030
  • Figure 8.10: Global IVF Embryo Culture Media and Reagents Market, 2019-2030
  • Figure 8.11: Global IVF Cryopreservation Media and Reagents Market, 2019-2030
  • Figure 8.12: Global IVF Gamete Processing Media and Reagents Market, 2019-2030
  • Figure 8.13: Global IVF Other Media and Reagents Market, 2019-2030
  • Figure 8.14: Global IVF Accessories and Consumables Market, 2019-2030
  • Figure 9.1: Global IVF Market (by Type), 2020 and 2030
  • Figure 9.2: Global Conventional IVF Market, 2019-2030
  • Figure 9.3: Global IVF with ICSI Market, 2019-2030
  • Figure 10.1: Global IVF Market (by Procedure), 2020 and 2030
  • Figure 10.2: Global IVF Fresh Donor Market, 2019-2030
  • Figure 10.3: Global IVF Fresh Non-donor Market, 2019-2030
  • Figure 10.4: Global IVF Frozen Donor Market, 2019-2030
  • Figure 10.5: Global IVF Frozen Non-donor Market, 2019-2030
  • Figure 11.1: Global IVF Market (by End Users), 2020 and 2030
  • Figure 11.2: Global IVF Commercial Labs Market, 2019-2030
  • Figure 11.3: Global IVF Fertility Clinics Market, 2019-2030
  • Figure 11.4: Global IVF Hospital Systems Market, 2019-2030
  • Figure 11.5: Global IVF Other End Users Market, 2019-2030
  • Figure 12.1: Global In-Vitro Fertilization Market (by Region)
  • Figure 12.2: Global In-Vitro Fertilization Market (by Region), $Million, 2020 and 2030
  • Figure 12.3: Global In-Vitro Fertilization Market (by Region), $Million, 2019-2030
  • Figure 12.4: North America In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.5: North America: Market Dynamics
  • Figure 12.6: Revenue Contributions of Various Countries in North America, 2019 and 2030
  • Figure 12.7: U.S. In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.8: Canada In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.9: North America In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
  • Figure 12.10: North America In-Vitro Fertilization Market (by End User), 2019-2030
  • Figure 12.11: Europe In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.12: Europe: Market Dynamics
  • Figure 12.13: Revenue Contributions of Various Countries in Europe, $Million, 2019 and 2030
  • Figure 12.14: Germany In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.15: France In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.16: U.K. In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.17: Italy In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.18: Spain In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.19: Netherlands In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.20: Russia In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.21: Rest-of-Europe In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.22: Europe In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
  • Figure 12.23: Europe In-Vitro Fertilization Market (by End User), $Million, 2019-2030
  • Figure 12.25: Asia-Pacific: Market Dynamics
  • Figure 12.26: Revenue Contributions of Various Countries in Asia-Pacific, $Million, 2019 and 2030
  • Figure 12.27: Japan In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.28: China In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.29: Australia In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.30: India In-Vitro fertilization Market, $Million, 2019-2030
  • Figure 12.31: South Korea In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.32: Singapore In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.33: Rest-of-APAC In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.34: APAC In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
  • Figure 12.35: APAC In-Vitro Fertilization Market (by End User), $Million, 2019-2030
  • Figure 12.36: Latin America In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.37: Latin America: Market Dynamics
  • Figure 12.38: Revenue Contributions of Various Countries in Latin America, $Million, 2019 and 2030
  • Figure 12.39: Brazil In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.40: Mexico In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.41: RoLA In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.42: Latin America In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
  • Figure 12.43: Latin America In-Vitro Fertilization Market (by End User), $Million, 2019-2030
  • Figure 12.44: Rest-of-the-World In-Vitro Fertilization Market, $Million, 2019-2030
  • Figure 12.45: Rest-of-the-World In-Vitro Fertilization Market (by Procedure), $Million, 2019-2030
  • Figure 12.46: Rest-of-the-World In-Vitro Fertilization Market (by End User), $Million, 2019-2030
  • Figure 13.1: Total Number of Companies Profiled
  • Figure 13.2: Total Number of Companies Profiled: Ratio of Suppliers to Service Providers
  • Figure 13.3: The Cooper Companies Inc.: Product Portfolio for Global IVF market
  • Figure 13.4: The Cooper Companies Inc.: Overall Financials, 2018-2020
  • Figure 13.5: The Cooper Companies Inc.: Revenue (by Segment), 2018-2020
  • Figure 13.6: The Cooper Companies Inc.: Revenue (by CooperSurgical Category), 2018-2020
  • Figure 13.7: The Cooper Companies Inc.: Revenue (by Region), 2018-2020
  • Figure 13.8: The Cooper Companies Inc.: R&D Expenditure (2018-2020)
  • Figure 13.9: The Cooper Companies Inc.: SWOT Analysis
  • Figure 13.10: Vitrolife AB: Product Portfolio for Global IVF market
  • Figure 13.11: Vitrolife AB: Overall Financials, 2018-2020
  • Figure 13.12: Vitrolife AB: Revenue (by Segment), 2018-2020
  • Figure 13.13: Vitrolife AB: Revenue (by Region), 2018-2020
  • Figure 13.14: Vitrolife AB: R&D Expenditure (2018-2020)
  • Figure 13.15: Vitrolife AB: SWOT Analysis
  • Figure 13.16: Illumina, Inc.: Overall Product Portfolio
  • Figure 13.17: Illumina, Inc.: Overall Financials, 2018-2020
  • Figure 13.18: Illumina, Inc.: Revenue (by Segment), 2018-2020
  • Figure 13.19: Illumina, Inc.: Revenue (by Region), 2018-2020
  • Figure 13.20: Illumina, Inc.: R&D Expenditure, 2018-2020
  • Figure 13.21: Illumina, Inc.: SWOT Analysis
  • Figure 13.22: Agilent Technologies, Inc.: Overall Product Portfolio
  • Figure 13.23: Agilent Technologies, Inc.: Overall Financials, 2018-2020
  • Figure 13.24: Agilent Technologies, Inc.: Revenue (by Segment), 2018-2020
  • Figure 13.25: Agilent Technologies, Inc.: Revenue (by Region), 2018-2020
  • Figure 13.26: Agilent Technologies, Inc. R&D Expenditure, 2018-2020
  • Figure 13.27: Agilent Technologies, Inc.: SWOT Analysis
  • Figure 13.28: Cook Medical: Product Portfolio for Global IVF Market
  • Figure 13.29: Cook Medical: SWOT Analysis
  • Figure 13.30: FUJIFILM Irvine Scientific: Product Portfolio for Global IVF market
  • Figure 13.31: FUJIFILM Irvine Scientific: SWOT Analysis
  • Figure 13.32: F. Hoffmann-La Roche Ltd.: Overall Product Portfolio
  • Figure 13.33: F. Hoffmann-La Roche Ltd.: Overall Financials, 2018-2020
  • Figure 13.34: F. Hoffmann-La Roche Ltd.: Revenue (by Segment), 2018-2020
  • Figure 13.35: F. Hoffmann-La Roche Ltd.: Revenue (by Region), 2018-2020
  • Figure 13.36: F. Hoffmann-La Roche Ltd.: R&D Expenditure, 2018-2020
  • Figure 13.37: F. Hoffmann-La Roche Ltd.: SWOT Analysis
  • Figure 13.38: GE Healthcare: Product Portfolio
  • Figure 13.39: GE Healthcare: Overall Financials, 2018-2020
  • Figure 13.40: GE Healthcare Net Revenue (by Segment), 2018-2020
  • Figure 13.41: GE Healthcare (by Region), 2018-2020
  • Figure 13.42: GE Healthcare R&D Expense, 2018-2020
  • Figure 13.43: GE Healthcare SWOT Analysis
  • Figure 13.44: Abbott Laboratories: Overall Product Portfolio
  • Figure 13.45: Abbott Laboratories: Overall Financials, 2018-2020
  • Figure 13.46: Abbott Laboratories: Revenue (by Segment), 2018-2020
  • Figure 13.47: Abbott Laboratories: Revenue (by Region), 2018-2020
  • Figure 13.48: Abbott Laboratories: R&D Expenditure, 2018-2020
  • Figure 13.49: Abbott Laboratories: SWOT Analysis
  • Figure 13.50: Thermo Fisher Scientific, Inc.: Overall Product Portfolio
  • Figure 13.51: Thermo Fisher Scientific, Inc.: In-Vitro Fertilization Product Portfolio Category
  • Figure 13.52: Thermo Fisher Scientific, Inc.: Overall Financials, 2018-2020
  • Figure 13.53: Thermo Fisher Scientific, Inc. Net Revenue (by Business Segment), 2018-2020
  • Figure 13.54: Thermo Fisher Scientific, Inc. Net Revenue (by Region), 2018-2020
  • Figure 13.55: Thermo Fisher Scientific, Inc.: R&D Expense, 2018-2020
  • Figure 13.56: Thermo Fisher Scientific, Inc.: SWOT Analysis
  • Figure 13.57: Merck KGaA: Overall Product Portfolio
  • Figure 13.58: Merck KGaA: Overall Financials, 2018-2020
  • Figure 13.59: Merck KGaA Net Revenue (by Business Segment), 2018-2020
  • Figure 13.60: Merck KGaA Net Revenue (by Region), 2018-2020
  • Figure 13.61: Merck KGaA: R&D Expense, 2018-2020
  • Figure 13.62: Merck KGaA: SWOT Analysis
  • Figure 13.63: Esco Group of Companies: Product Portfolio for Global IVF market
  • Figure 13.64: Esco Group of Companies: SWOT Analysis
  • Figure 13.65: IVFtech ApS: Product Portfolio for Global IVF market
  • Figure 13.66: IVFtech ApS: SWOT Analysis
  • Figure 13.67: Kitazato Corporation: Overall Product Portfolio
  • Figure 13.68: Kitazato Corporation: SWOT Analysis
  • Figure 13.69: Care Fertility: Overall Product Portfolio
  • Figure 13.70: Care Fertility: SWOT Analysis
  • Figure 13.71: Labcorp: Overall Service Portfolio
  • Figure 13.72: Labcorp: Overall Financials, 2018-2020
  • Figure 13.73: Labcorp Net Revenue (by Business Segment), 2018-2020
  • Figure 13.74: Labcorp Net Revenue (by Region), 2018-2020
  • Figure 13.75: Labcorp: SWOT Analysis
  • Figure 13.76: Genea Limited: Overall Product Portfolio
  • Figure 13.77: Genea Limited: SWOT Analysis
  • Figure 13.78: Natera Inc.: Overall Product Portfolio
  • Figure 13.79: Natera, Inc.: Overall Financials, 2016-2018
  • Figure 13.80: Natera, Inc Net Revenue (by Business Segment), 2016-2018
  • Figure 13.81: Natera, Inc. Net Revenue (by Region), 2016-2018
  • Figure 13.82: Natera, Inc Research and Development Revenue, 2016-2018
  • Figure 13.83: Natera Inc.: SWOT Analysis
  • Figure 13.84: Invitae Corporation: Overall Product Portfolio
  • Figure 13.85: Invitae Corporation: Overall Financials, 2018-2020
  • Figure 13.86: Invitae Corporation Net Revenue (by Region), 2018-2020
  • Figure 13.87: Invitae Corporation Research and Development Revenue, 2018-2020
  • Figure 13.88: Invitae Corporation: SWOT Analysis
  • Figure 13.89: Progyny, Inc.: Overall Product Portfolio
  • Figure 13.90: Progyny Inc.: Overall Financials, 2018-2020
  • Figure 13.91: Progyny, Inc.: SWOT Analysis
  • Figure 13.92: Kaiser Permanente: Overall Product Portfolio
  • Figure 13.93: Kaiser Permanente: SWOT Analysis
  • Figure 13.94: Boston IVF: Overall Product Portfolio
  • Figure 13.95: Boston IVF: SWOT Analysis
  • Figure 13.96: Monash IVF: Overall Product Portfolio
  • Figure 13.97: Monash IVF: Overall Financials, 2018-2020
  • Figure 13.98: Monash IVF: SWOT Analysis